14-day Premium Trial Subscription Sign Up For FreeGet Free

Cytokinetics Stock Forecast NASDAQ:CYTK

Price Target and Analyst Ratings

Most Recent Rating

On September 07, 2021 "Barclays" gave "$40.00 - $45.00" rating for CYTK. The price target was changed from $32.46 to 3.2%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-07 $40.00 - $45.00 Target Raised by Barclays $31.05 $32.46→3.2%
2021-08-09 $42.00 - $40.00 Target Lowered by Piper Sandler $31.89 $31.82+5.2%
2021-08-06 $53.00 - $58.00 Target Raised by HC Wainwright $31.82 $30.24+2.5%
2021-07-20 $35.00 - $48.00 Target Raised by Cantor Fitzgerald $29.18 $27.00+40.4%
2021-07-20 $28.00 - $40.00 Target Raised by Barclays $29.18 $27.00+40.4%
2021-07-19 $37.00 - $54.00 Target Raised by Raymond James $27.00 $27.20+41.4%
2021-07-19 $25.00 - $42.00 Target Raised by Piper Sandler $27.00 $27.20+41.4%
2021-07-19 $26.00 - $44.00 Target Raised by JMP Securities $27.00 $27.20+41.4%
2021-07-19 $41.00 - $53.00 Target Raised by HC Wainwright $27.00 $28.28+47.1%
2021-07-19 $33.00 - $48.00 Target Raised by Needham & Company LLC $27.00 $28.78+49.7%
2021-07-01 $36.00 Initiated by Mizuho $20.98 $19.59→0.7%
2021-07-01 Buy Initiated by Mizuho $20.98 $36.00
2021-05-11 Buy Target Raised by Mizuho $23.77 $26.00 → $36.00
2021-04-26 Overweight Target Raised by Morgan Stanley $26.99 $24.00 → $35.00
2021-04-19 Overweight Target Raised by Morgan Stanley $24.73 $24.00 → $35.00
2021-03-17 Outperform Initiated by Wolfe Research $25.68 $50.00
2021-03-11 Outperform Initiated by Wolfe Research $20.30 $50.00
2021-03-11 Outperform Initiated by Wolfe Research $20.30
2021-02-18 Overweight Initiated by Barclays $21.01 $28.00
2021-01-20 Buy Target Raised by HC Wainwright $19.98 $22.00 → $41.00
2020-12-16 Overweight Target Raised by Morgan Stanley $21.00 $22.00 → $24.00
2020-12-14 Buy Target Lowered by Mizuho $21.24 $31.00 → $26.00
2020-11-24 Buy Reiterated by Raymond James $16.49
2020-11-23 Buy Target Lowered by HC Wainwright $16.07 $43.00 → $22.00
2020-11-16 Buy Reiterated by Needham & Company LLC $15.59 $33.00
2020-11-16 Overweight Target Lowered by Morgan Stanley $15.59 $24.00 → $22.00
2020-10-28 Neutral Initiated by The Goldman Sachs Group $15.35 $16.00
2020-10-12 Overweight Target Lowered by Morgan Stanley $15.65 $35.00 → $24.00
2020-10-08 Positive - Buy Target Lowered by HC Wainwright $16.00 $59.00 → $43.00
2020-10-08 Buy Target Lowered by HC Wainwright $16.00 $59.00 → $43.00
2020-10-06 Overweight Target Raised by Cantor Fitzgerald $28.55 $41.00 → $48.00
2020-07-23 Buy Target Raised by HC Wainwright $24.23 $38.00 → $59.00
2020-07-23 Overweight Target Raised by Piper Sandler $24.23 $33.00 → $36.00
2020-07-15 Overweight Target Raised by Cantor Fitzgerald $28.96 $29.00 → $41.00
2020-07-15 Outperform Target Raised by JMP Securities $28.96 $23.00 → $29.00
2020-07-14 Buy Target Raised by HC Wainwright $27.88 $35.00 → $38.00
2020-07-14 Target Raised by Piper Sandler $27.88 $28.00 → $33.00
2020-07-14 Buy Target Raised by Needham & Company LLC $27.88 $34.00 → $45.00
2020-07-10 Strong-Buy Initiated by Raymond James $25.50 $39.00
2020-05-12 Overweight Target Raised by Morgan Stanley $20.96 $25.00 → $29.00
2020-05-11 Positive - Buy Target Raised by HC Wainwright $20.99 $30.00 → $35.00
2020-05-07 Buy Reiterated by Needham & Company LLC $15.73 $24.00
2020-05-04 Buy Initiated by Mizuho $15.17
2020-04-27 Buy Reiterated by Morgan Stanley $15.65 $25.00
2020-04-24 Buy Reiterated by HC Wainwright $15.68
2020-04-19 Equal Weight - Overweight Upgraded by Morgan Stanley $15.24
2020-04-17 Overweight Target Raised by Cantor Fitzgerald $15.24 $12.00 → $23.00
2020-04-14 Buy Reiterated by Needham & Company LLC $13.55 $24.00
2020-04-09 Equal Weight - Overweight Upgraded by Morgan Stanley $13.89 $14.00 → $25.00

CYTK Stock Trend

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 62.34% during the next 3 months and, with a 90% probability hold a price between $49.56 and $60.24 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-30 $30.75 $34.04 $37.33
2021-10-01 $30.98 $34.27 $37.56
2021-10-04 $31.21 $34.50 $37.78
2021-10-05 $31.43 $34.72 $38.01
2021-10-06 $31.66 $34.95 $38.24
2021-10-07 $31.88 $35.17 $38.46
2021-10-08 $32.11 $35.40 $38.69
2021-10-11 $32.34 $35.63 $38.92
2021-10-12 $32.56 $35.85 $39.14
2021-10-13 $32.79 $36.08 $39.37
2021-10-14 $33.02 $36.30 $39.59
2021-10-15 $33.24 $36.53 $39.82
2021-10-18 $33.47 $36.76 $40.05
2021-10-19 $33.69 $36.98 $40.27
2021-10-20 $33.92 $37.21 $40.50
2021-10-21 $34.15 $37.44 $40.72
2021-10-22 $34.37 $37.66 $40.95
2021-10-25 $34.60 $37.89 $41.18
2021-10-26 $34.82 $38.11 $41.40
2021-10-27 $35.05 $38.34 $41.63
2021-10-28 $35.28 $38.57 $41.86
2021-10-29 $35.50 $38.79 $42.08
2021-11-01 $35.73 $39.02 $42.31
2021-11-02 $35.96 $39.24 $42.53
2021-11-03 $36.18 $39.47 $42.76
2021-11-04 $36.41 $39.70 $42.99
2021-11-05 $36.63 $39.92 $43.21
2021-11-08 $36.86 $40.15 $43.44
2021-11-09 $37.09 $40.38 $43.66
2021-11-10 $37.31 $40.60 $43.89

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. It is developing tirasemtiv, a fast skeletal muscle troponin activator that is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis; CK-2127107, which is in Phase II clinical trials for... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT